Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Róbert_Wessman
|
| gptkbp:focusesOn |
biosimilars
specialty pharmaceuticals |
| gptkbp:foundedIn |
2009
|
| gptkbp:founder |
gptkb:Róbert_Wessman
|
| gptkbp:headquartersLocation |
gptkb:Pine_Brook,_New_Jersey,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Alvogen
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:numberOfEmployees |
over 2,800
|
| gptkbp:operatesIn |
over 35 countries
|
| gptkbp:parentCompany |
gptkb:Aztiq_Pharma_Partners
gptkb:Pamplona_Capital_Management gptkb:CVC_Capital_Partners gptkb:Temasek_Holdings |
| gptkbp:products |
generic drugs
over-the-counter medicines branded pharmaceuticals |
| gptkbp:subsidiary |
gptkb:Alvotech
|
| gptkbp:website |
https://www.alvogen.com/
|
| gptkbp:bfsParent |
gptkb:CVC_Capital_Partners
|
| gptkbp:bfsLayer |
6
|